1Andrew J. Schoenfeld,Francis J. Hornicek,Francis X. Pedlow,Wendy Kobayashi,Ronald T. Garcia,Thomas F. DeLaney,Dempsey Springfield,Henry J. Mankin,Joseph H. Schwab.Osteosarcoma of the spine: experience in 26 patients treated at the Massachusetts General Hospital[J].The Spine Journal.2010(8)
2Rangaiah Shashidharamurthy,Erica N. Bozeman,Jaina Patel,Ramneet Kaur,Jeyandra Meganathan,Periasamy Selvaraj.Immunotherapeutic strategies for cancer treatment: A novel protein transfer approach for cancer vaccine development[J].Med Res Rev.2011(6)
3Marta Hegyi,ágnes Gulácsi,Edit Cságoly,Katalin Csordás,Olivér Eipel,Dániel Erdélyi,Judit Müller,Karolina Nemes,Orsolya Lautner-Csorba,Gábor Kovács.Clinical relations of methotrexate pharmacokinetics in the treatment for pediatric osteosarcoma[J].Journal of Cancer Research and Clinical Oncology.2012(10)
4Yong Ding,Yucai Wang,Jun Chen,Yunsheng Hu,Zhuo Cao,Pengcheng Ren,Yong Zhang.p21 overexpression sensitizes osteosarcoma U2OS cells to cisplatin via evoking caspase-3 and Bax/Bcl-2 cascade[J].Tumor Biology.2014(4)
5Norio Yamamoto,Hiroyuki Tsuchiya.Chemotherapy for osteosarcoma – Where does it come from? What is it? Where is it going?[J].Expert Opinion on Pharmacotherapy.2013(16)
6Sulagna Banerjee,Venugopal Thayanithy,Veena Sangwan,Tiffany N. Mackenzie,Ashok K. Saluja,Subbaya Subramanian.Minnelide reduces tumor burden in preclinical models of osteosarcoma[J].Cancer Letters.2013(2)
7Zheng-Xiao Ouyang,Xian-An Li.Inhibitory effects of tamoxifen and doxorubicin, alone and in combination,on the proliferation of the MG63 human osteosarcoma cell line[J].Oncology Letters.2013(4)
8Masanori Kawano,Ichiro Itonaga,Tatsuya Iwasaki,Hiroshi Tsumura.Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyteantigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murineosteosarcoma[J].Oncology Reports.2013(3)
6Gelderblom H, Jinks RC, Sydes M, et al. Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials[J]. Eur J Cancer, 2011, 47(6): 895-902.
7Janeway KA, Grier HE. Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects[J]. Lancet Oncol, 2010, 11(7): 670-678.
8Bacci G, Longhi A, Fagioli F, et al. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy[J]. Eur J Cancer, 2005, 41(18): 2836-2845.
9Pring ME, Weber KL, Unni KK, et al. Chondrosarcoma of the pelvis. A review of sixty-four cases[J]. J Bone Joint Surg Am, 2001, 83-A(11): 1630-1642.
